<DOC>
	<DOCNO>NCT02260388</DOCNO>
	<brief_summary>The purpose large comparative effectiveness study lead Richard J. Barohn , MD , University Kansas Medical Center , learn safety effectiveness nortriptyline , duloxetine , pregabalin mexiletine treat cryptogenic sensory polyneuropathy ( CSPN ) .</brief_summary>
	<brief_title>Patient Assisted Intervention Neuropathy : Comparison Treatment Real Life Situations</brief_title>
	<detailed_description>The goal research project find best drug treatment pain patient CSPN . While pharmaceutical industry focus attention drug treat diabetic sensory neuropathy ( DSPN ) , two drug FDA approve , prospective trial CSPN . And , study CSPN patient , insurance carrier often reject authorize prescription drug patient CSPN . There four drug test study : nortriptyline , duloxetine , pregabalin mexiletine . These drug approve FDA treatment CSPN consider `` investigational '' study . There two period study : Screening/Baseline Study Drug . During Screening/Baseline period researcher determine eligibility potential subject . During second period , eligible patient consented participate take study drug . Participants randomize receive one four drug study . Participants know drug taking . Participants allow switch group receive different drug study . This study use adaptive study design . This mean study enroll less participant provide good conclusion . The study design allow researcher ability make change approach study stop study early strong result .</detailed_description>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<mesh_term>Mexiletine</mesh_term>
	<criteria>Diagnosis cryptogenic sensory polyneuropathy . Likert Pain Score great equal 4 . Must currently nortriptyline , duloxetine , pregabalin mexiletine similar class medication least 7 day baseline study visit . Any medical condition current medication would prevent take either nortriptyline , duloxetine , pregabalin mexiletine . Unable give consent . Unable willing comply study . Other cause polyneuropathy .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CSPN</keyword>
	<keyword>neuropathy</keyword>
	<keyword>pain</keyword>
	<keyword>pain management</keyword>
</DOC>